Indaptus Therapeutics (INDP) Other Operating Expenses (2024 - 2025)
Indaptus Therapeutics (INDP) posted quarterly Other Operating Expenses of $43254.0 for Q4 2025, up 6.74% year-over-year from $40523.0 in Q4 2024, and up 10.66% quarter-over-quarter from $39088.0 in Q3 2025.
Indaptus Therapeutics (INDP) Other Operating Expenses (2024 - 2025) Analysis & Trends
Indaptus Therapeutics' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $43254.0 for Q4 2025.
- In Q4 2025, Other Operating Expenses rose 6.74% year-over-year to $43254.0; the TTM figure through Mar 2026 stood at $97889.0 (down 60.42% YoY), while the FY2025 annual figure was $138018.0, down 59.85% from the prior year.
- Other Operating Expenses for Q4 2025 stood at $43254.0, up from $39088.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $136562.0 in Q1 2024, with the low at $15547.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Indaptus Therapeutics | 157.94 Mn | 146.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43,254.00 |
| Sep 30, 2025 | 39,088.00 |
| Jun 30, 2025 | 15,547.00 |
| Mar 31, 2025 | 40,129.00 |
| Dec 31, 2024 | 40,523.00 |
| Sep 30, 2024 | 73,021.00 |
| Jun 30, 2024 | 93,618.00 |
| Mar 31, 2024 | 136,562.00 |